Aidapak Recalls Ascorbic Acid Tablets Due to Potential Label Mixup
Aidapak Services, LLC is recalling 250 mg Ascorbic Acid tablets because they may have been mislabeled as other prescription or over-the-counter drugs.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, and the rubric specifies that FDA Class II recalls with potential for significant injury (such as taking the wrong medication) are classified as Severe.
Plain-English summary
Aidapak Services, LLC is recalling 3,301 tablets of Ascorbic Acid, 250 mg, Over The Counter (NDC 00904052260). The recall is due to a labeling error where the Ascorbic Acid tablets may have been mislabeled as various other medications, including Pregabalin, Nifedipine, Pimozide, and Quetiapine Fumarate.
The repacked drugs were distributed in Arizona, California, Oregon, and Washington. The source text does not specify the exact number of affected units or specific lot numbers beyond the NDC and pedigree codes listed for the potential mislabels.
Consumers should check their medication bottles to ensure they contain the correct drug. If a bottle of Ascorbic Acid, 250 mg, is labeled as one of the drugs listed in the recall notice, consumers should stop using the product and contact their pharmacist or healthcare provider for guidance.
The recalled product
- Product
- ASCORBIC ACID, Tablet, 250 mg, Over The Counter, Distributed by: AidaPak Service, LLC, NDC 00904052260.
- Manufacturer
- Aidapak Services, LLC
- Category
- Drug — Over-The-Counter
- Hazard
- Affected units
- 3,301
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- ASCORBIC ACID
- Tablet
- Capsule
- 200 mg
- NDC 00071101768
- Pedigree: AD30024_1
- EXP: 5/9/2014
- NIFEDIPINE
- 10 mg
- NDC 43386044024
- Pedigree: AD23082_10
- EXP: 9/23/2013
- PIMOZIDE
- 2 mg
- NDC 57844018701
- Pedigree: AD30140_43
- EXP: 5/7/2014
- OMEGA-3-ACID ETHYL ESTERS
- 1000 mg
- NDC 00173078302
Distribution
Part of a larger recall action
This product is one of 265 recalled by Aidapak Services, LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 265 products in this recall →Related recalls
Same manufacturer · Aidapak Services, LLC
See all →- ModerateAidapak Recalls Sennosides Tablets Due to Potential Labeling Errors
FDA (Drugs) · 2014-01-29
- ModerateLevothyroxine Sodium Tablets Recalled for Potential Labeling Mixup
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Mislabeled Pantoprazole Sodium DR Tablets
FDA (Drugs) · 2014-01-29
- ModerateAidapak Recalls Nifedipine ER Tablets Due to Potential Label Mixup
FDA (Drugs) · 2014-01-29
- ModerateSimvastatin Tablets Recalled for Potential Labeling Error
FDA (Drugs) · 2014-01-29
Same hazard · mis labeling
See all →- ModerateMedline Trach Tube Kit Recalled for Component Labeling Discrepancy
FDA (Devices) · 2026-09-02
- ModerateAVID Medical Recalls Halyard Total Joint Kits for Latex Labeling Deficiency
FDA (Devices) · 2026-09-02
- ModerateOlympus Recalls PowerSeal Sealer Due to Incorrect Outer Box Labeling
FDA (Devices) · 2026-09-02
- HighSura Tanmen Ramen Noodles Recalled for Undeclared Fish Allergens
FDA (Food) · 2026-09-02
- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-09-02